SEC Form 4 · accession 0001415889-16-005181
MetaStat, Inc. · MTST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel H Schneiderman
Officer — VP OF FINANCE AND SECRETARY
Period of report
Feb 3, 2016
Accepted (ET)
Mar 18, 2016 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404943
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase Common StockF1 | $3.55 | Feb 3, 2016 | A | 20,000 | A | — | Feb 3, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F15,000 of such stock options vested upon issuance and 15,000 stock options vest upon release of clinical data in connection with the company's ECOG 2197 breast cancer clinical trial.